Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
DNA4Life Is Latest DTC Genetic Test Company to Receive FDA Letter
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Direct-to-consumer startup DNA4Life (Mandeville, La.) is the latest recipient of a letter from the U.S. Food and Drug Administration (FDA) questioning the company's marketing of an unapproved...
Harmonyx Tests to Be Distributed Through Rite Aid
By Ron Shinkman, Editor, Laboratory Industry Report Harmonyx, the Tennessee-based molecular laboratory, has struck a deal with pharmacy chain Rite Aid to sell its pharmacogenetic assays at its retail stores. Customers will be able to purchase the Harmonyx test at...
HCCA Offers Compliance Officer and Staff Compensation Survey
By Kelly A. Briganti, Editorial Director, G2 Intelligence Just in time for budget season, the Health Care Compliance Association has released a report demonstrating the resources health care organizations are devoting to their compliance programs. The report...
OIG Releases 2016 Work Plan; Report on Lab Payments Expected
By Kelly A. Briganti, Editorial Director, G2 Intelligence Last week the OIG released its 2016 Work Plan that continues to name laboratories as a source of concern with regard to Medicare billing and payment. The OIG's annual Work Plan provides a summary of new and...
Study Questions Clinical Impact of “Choosing Wisely” Recommendations
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies An initial assessment shows that the Choosing Wisely campaign is not having a large impact on changing use of low-value services, according to a paper published online Oct. 12 in JAMA Internal...